Gainers
Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 30 points on Wednesday.
The Dow traded up 0.12% to 32,695.97 while the NASDAQ fell 0.23% to 11,429.16. The S&P 500 also fell, dropping, 0.17% to 3,963.32.
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like Apple Inc.
Amplify Energy (NYSE:AMPY) reported quarterly earnings of $1.17 per share. This is a 434.29 percent increase over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.